
Investing in Ionis Pharmaceuticals Inc (IONS) Is Getting More Attractive
In a filing, Ionis Pharmaceuticals Inc revealed its Director PARSHALL B LYNNE unloaded Company’s shares for reported $0.21 million on
In a filing, Ionis Pharmaceuticals Inc revealed its Director PARSHALL B LYNNE unloaded Company’s shares for reported $0.21 million on
Ionis Pharmaceuticals Inc’s recently made public that its Officer Schneider Eugene acquired Company’s shares for reported $0.41 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Ionis Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Monia Brett P unloaded Company’s shares for reported $48416.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Ionis Pharmaceuticals Inc revealed its Chief Executive Officer Monia Brett P unloaded Company’s shares for reported $48416.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ionis Pharmaceuticals
Ionis Pharmaceuticals Inc’s recent filing unveils that its Director Hayden Michael R acquired Company’s shares for reported $0.48 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Ionis Pharmaceuticals Inc’s recent filing unveils that its Director Hayden Michael R acquired Company’s shares for reported $0.48 million on